Skin Analytics logo — AI for Skin Cancer Detection

Skin Analytics

AI for Skin Cancer Detection

Founded 2012 United Kingdom London, United Kingdom 85 employees Series B Total: $25.95M AI, Analytics +3

General Information

Company Name Skin Analytics
Founded Year 2012
Location United Kingdom London, United Kingdom +1
Employees 85
Industries AI, Analytics, Digital Health +2
Funding Stage Series B
Social

Get notified when Skin Analytics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Skin Analytics

Skin Analytics, founded in 2012, is a UK-based startup revolutionizing skin cancer detection with its AI medical device, DERM. The company's mission to eliminate skin cancer deaths is evident in its partnership with 18 NHS dermatology teams, deploying AI-powered skin cancer pathways. DERM, the first and only AI skin cancer pathway within the NHS, is a Class IIa UKCA marked and Class III CE marked AI medical device, having identified over 13,000 cancers in pathways that have served more than 135,000 NHS patients. The company's commitment to improving patient outcomes and sustainability is underscored by its impact on NHS organizations, enabling them to discharge benign lesions earlier, thus addressing backlog, reducing out-patient delays, and prioritizing patients in need of life-saving treatment. Skin Analytics' impressive track record, including a Series B investment of €17.50M led by Intrepid Growth Partners on 16 April 2025, speaks to its significant potential in the AI, Analytics, Digital Health, Health Care, and Machine Learning industries. Additionally, the company's provision of remote skin assessment services to Bupa and Vitality signifies its commitment to expanding access to advanced skin care solutions.

Taxonomy: AI medical device, skin cancer detection, NHS partnership, DERM AI software, dermatology capacity management, remote skin assessment, digital skin history, consumer health technology, clinical skin conditions, skin health products, healthcare sustainability, patient outcomes, digital health platforms, skin health personalization

Funding Rounds & Investors (18)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 1 •••• •••• 16 Apr 2025
Series A •••••• 1
Investor
15 Sep 2022
Grant •••••• 1
Investor
01 Feb 2022
Series A •••••• 5
Investor Investor Investor Investor
•••• ••••
08 Sep 2020
Seed Round •••••• 1
Investor
20 Jan 2019

View All 18 Funding Rounds

Skin Analytics Alternatives & Competitors

Skin Analytics vs

Do what you love, and leave the skin care to us.

91 employees
Health Care, Wellness Beauty
Skin Analytics vs

Same day GP appointments and prescription medication.

59 employees
E-Commerce, Health Care

FAQ About Skin Analytics

AI for Skin Cancer Detection
Skin Analytics was founded in 2012.
Skin Analytics is headquartered in London, United Kingdom.
Skin Analytics operates in the following industries: AI, Analytics, Digital Health, Health Care, Machine Learning.
Skin Analytics has approximately 85 employees.
Skin Analytics has completed 18 funding rounds, raising a total of $25.95M. The latest funding stage is Series B.
Top alternatives and competitors to Skin Analytics include Skin Cancer & Dermatology Institute, LloydsPharmacy Online Doctor. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Skin Analytics and Skin Cancer & Dermatology Institute are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Skin Analytics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy